Literature DB >> 26991523

Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?

Stephen T Sonis1, Rui Amaral Mendes2.   

Abstract

The association between chronic inflammatory disorders and oral carcinogenesis has been both a source of interest and contention. Based upon its central importance in oral carcinogenesis, the finding that the PI3k/Akt/mTOR pathway is activated in oral lichen planus, chronic graft-versus-host disease, and chronic oral candidiasis suggests that it may provide a link between benign and malignant oral conditions. Here, we discuss a possible mechanistic rationale that addresses the activation of this important signaling pathway and its downstream events, while correlating it with the carcinogenic potential of chronic oral disorders.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PI3K signaling pathways; candidiasis; graft-vs.-host disease; inflammation; lichen planus; oral carcinogenesis

Mesh:

Substances:

Year:  2016        PMID: 26991523     DOI: 10.1111/jop.12436

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

Review 1.  Oral lichenoid lesions: distinguishing the benign from the deadly.

Authors:  Susan Müller
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  A genome-wide association scan of biological processes involved in oral lichen planus and oral squamous cell carcinoma.

Authors:  Qiaozhen Yang; Beiyun Xu; Hongying Sun; Xiaxia Wang; Jie Zhang; Xuedi Yu; Xiaojuan Ma
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  Inhibition of Phosphatidylinositol 3-kinease suppresses formation and progression of experimental abdominal aortic aneurysms.

Authors:  Jing Yu; Rui Liu; Jianhua Huang; Lixin Wang; Wei Wang
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

Review 4.  Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Authors:  Choudhary Harsha; Kishore Banik; Hui Li Ang; Sosmitha Girisa; Rajesh Vikkurthi; Dey Parama; Varsha Rana; Bano Shabnam; Elina Khatoon; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

5.  Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.

Authors:  MingBo Wei; YanLi Wu; Hui Liu; Chun Xie
Journal:  Drug Des Devel Ther       Date:  2020-01-29       Impact factor: 4.162

6.  Increased SNAT1 is a marker of human osteosarcoma and potential therapeutic target.

Authors:  Miaomiao Wang; Ying Liu; Wenzheng Fang; Ke Liu; Xiaodong Jiao; Zhan Wang; Jiejun Wang; Yuan-Sheng Zang
Journal:  Oncotarget       Date:  2017-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.